Principal Financial Group’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,806
Closed -$34.9K 2397
2024
Q1
$34.9K Sell
13,806
-32,745
-70% -$73.8K ﹤0.01% 2369
2023
Q4
$112K Buy
46,551
+7,263
+18% +$17.1K ﹤0.01% 2258
2023
Q3
$134K Sell
39,288
-240,031
-86% -$1.33M ﹤0.01% 2229
2023
Q2
$2.05M Sell
279,319
-12,319
-4% -$114K ﹤0.01% 1762
2023
Q1
$3.02M Sell
291,638
-7,188
-2% -$86.9K ﹤0.01% 1689
2022
Q4
$3.53M Buy
298,826
+24,975
+9% +$386K ﹤0.01% 1646
2022
Q3
$5.75M Sell
273,851
-2,399
-0.9% -$66.8K ﹤0.01% 1449
2022
Q2
$8.57M Sell
276,250
-39,766
-13% -$1.36M 0.01% 1341
2022
Q1
$13M Sell
316,016
-2,572
-0.8% -$113K 0.01% 1224
2021
Q4
$13.8M Buy
318,588
+152,961
+92% +$6.92M 0.01% 1209
2021
Q3
$8.29M Buy
165,627
+5,224
+3% +$316K 0.01% 1492
2021
Q2
$10.1M Sell
160,403
-13,803
-8% -$887K 0.01% 1426
2021
Q1
$16.2M Buy
174,206
+20,962
+14% +$2.15M 0.01% 1090
2020
Q4
$13.7M Buy
153,244
+15,958
+12% +$1.46M 0.01% 1040
2020
Q3
$14.2M Sell
137,286
-203,378
-60% -$21.9M 0.01% 860
2020
Q2
$26.9M Sell
340,664
-6,447
-2% -$480K 0.02% 528
2020
Q1
$20.1M Sell
347,111
-13,843
-4% -$798K 0.02% 557
2019
Q4
$19.5M Buy
360,954
+7,125
+2% +$386K 0.02% 816
2019
Q3
$18.5M Sell
353,829
-15,469
-4% -$721K 0.02% 828
2019
Q2
$17.8M Sell
369,298
-16,471
-4% -$789K 0.02% 851
2019
Q1
$19.5M Sell
385,769
-1,749
-0.5% -$103K 0.02% 807
2018
Q4
$23M Buy
387,518
+3,894
+1% +$251K 0.02% 629
2018
Q3
$25.3M Buy
383,624
+82,430
+27% +$4.81M 0.02% 703
2018
Q2
$15.2M Buy
301,194
+9,119
+3% +$475K 0.01% 1017
2018
Q1
$15.4M Buy
292,075
+7,367
+3% +$367K 0.01% 978
2017
Q4
$13.2M Buy
284,708
+19,791
+7% +$833K 0.01% 1091
2017
Q3
$10.7M Sell
264,917
-614
-0.2% -$22.2K 0.01% 1198
2017
Q2
$9M Sell
265,531
-12,239
-4% -$378K 0.01% 1289
2017
Q1
$8.07M Buy
277,770
+10,446
+4% +$318K 0.01% 1314
2016
Q4
$8.78M Buy
267,324
+14,874
+6% +$446K 0.01% 1249
2016
Q3
$7.96M Buy
252,450
+31,824
+14% +$925K 0.01% 1249
2016
Q2
$6.2M Buy
220,626
+9,020
+4% +$354K 0.01% 1326
2016
Q1
$7.69M Buy
211,606
+5,683
+3% +$201K 0.01% 1156
2015
Q4
$8.24M Buy
205,923
+14,751
+8% +$514K 0.01% 1077
2015
Q3
$5.45M Buy
191,172
+702
+0.4% +$23.1K 0.01% 1311
2015
Q2
$6.28M Buy
190,470
+7,211
+4% +$224K 0.01% 1312
2015
Q1
$5.27M Buy
183,259
+5,837
+3% +$167K 0.01% 1353
2014
Q4
$4.83M Buy
177,422
+1,542
+0.9% +$36.7K 0.01% 1401
2014
Q3
$3.75M Sell
175,880
-4,047
-2% -$92.7K 0.01% 1479
2014
Q2
$4.04M Sell
179,927
-4,826
-3% -$112K 0.01% 1486
2014
Q1
$4.67M Buy
184,753
+8,291
+5% +$209K 0.01% 1398
2013
Q4
$4.06M Buy
176,462
+8,348
+5% +$174K 0.01% 1461
2013
Q3
$3.2M Buy
168,114
+20,654
+14% +$369K 0.01% 1506
2013
Q2
$2.13M Buy
+147,460
New +$2.14M ﹤0.01% 1589

Other funds holding EBS